Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL97702 | 0.92 | THRB (0.42) | THRBTSHR | |
| SCHEMBL18499633 | 0.83 | THRB (0.49) | THRBTSHR | |
| SCHEMBL97562 | 0.83 | TSHR (0.46) | THRBTSHR | |
| SCHEMBL97696 | 0.82 | TSHR (0.49) | THRBTSHR | |
| SCHEMBL18499611 | 0.81 | THRB (0.45) | THRBTSHR | |
| SCHEMBL19296108 | 0.81 | THRB (0.41) | THRBTSHR | |
| SCHEMBL12159373 | 0.81 | THRB (0.38) | THRBTSHR | |
| SCHEMBL14299630 | 0.81 | THRB (0.34) | THRBTSHR | |
| SCHEMBL28068158 | 0.80 | TSHR (0.50) | THRBTSHR | |
| SCHEMBL26488793 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9024058-B2 | Ammonium fluoroalkanesulfonates and a synthesis method therefor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-05-05 | — | — | US | disclosed |
| US-20120004447-A1 | Ammonium Fluoroalkanesulfonates and a Synthesis Method Therefor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004447-A1 | Ammonium Fluoroalkanesulfonates and a Synthesis Method Therefor | NOTUM, FAR1, PFAS | THRB 4247/4885TSHR 3858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.